Clarus Lifesciences Ii, L.P.

Achillion Pharmaceuticals, Inc.

10% Owner

Avg. Two Year Performance

145% Avg. Purchase Return 57% Compound

19% Avg. Sale Return 9% Compound

Holdings: 3 shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions